![]() |
|
|
Vol. 302, Issue 2, 606-611, August 2002
Department of Pharmacology, University of Tennessee Health Science
Center, Memphis, Tennessee
Previous work has shown that the discriminative stimulus effects of
centrally administered isoproterenol are mediated primarily via
1-adrenergic receptors. In the present study, this model was used to
investigate the ability of antidepressant drugs displaying various
pharmacological profiles to stimulate
1-adrenergic receptors in
vivo; this was assessed by determining whether they substituted for the
discriminative stimulus effects of isoproterenol. Rats were trained to
discriminate centrally administered isoproterenol (10 µg i.c.v.) from
artificial cerebral spinal fluid using a water-reinforced, two-lever operant task (fixed ratio 10 schedule). After acquisition of
the discrimination, drugs were tested for substitution (i.p.). The
tricyclic antidepressants protriptyline and desipramine, the norepinephrine uptake inhibitor nisoxetine, the monoamine oxidase inhibitor phenelzine, and the atypical antidepressants bupropion, mirtazapine, and venlafaxine all produced greater than 90%
isoproterenol-appropriate responding. The serotonin uptake inhibitor
fluoxetine, the atypical antidepressants buspirone and trazodone, and
the novel, putative antidepressants
NG-nitro-L-arginine and
N-acetyl-L-tryptophan 3,5-bis benzyl ester failed to substitute for isoproterenol at the dose ranges tested. Antagonism studies carried out with betaxolol for those drugs that
fully generalized to isoproterenol's cue verified mediation by
1-adrenergic receptors. The present results indicate that drugs with
noradrenergic activity generalize to isoproterenol's discriminative
stimulus. Although this suggests a role for central
1-adrenergic
receptors in the mechanism of action of certain antidepressant drugs,
it does not seem that stimulation of these receptors is an effect
shared by antidepressants from all pharmacological classes.